Imunon General Counsel Susan Eylward disposes of 2,449 common shares worth $3,992.54PUBT·Aug 17 at 03:18 PMIMNN+4.40%
Imunon: Buy Rating Reiterated as Phase 3 IMNN-001 Progress and Extended Cash Runway Support Unchanged $10 Price TargetTip Ranks·Aug 12 at 12:15 PMIMNN+4.40%
Imunon menawarkan opsi gaji berbasis saham bagi eksekutif hingga 100% dari gaji pokok, dengan tambahan saham insentifPUBT·Aug 11 at 04:01 PMIMNN+4.40%
IMNN: Phase III enrollment exceeds plan, financials stable, and IMNN-001 shows strong clinical promiseQuartr·Aug 11 at 11:51 AMIMNN+4.40%
IMNN: Net loss of $7.1M in H1 2026; IMNN-001 Phase 3 enrollment ahead, but going concern risk remainsQuartr·Aug 11 at 07:50 AMIMNN+4.40%
IMNN: Strong clinical progress for IMNN-001 and $10M financing support ongoing late-stage trialsQuartr·Aug 11 at 07:35 AMIMNN+4.40%
Imunon says Phase 3 OVATION 3 ovarian cancer trial enrollment outpaces planPUBT·Jul 30 at 08:01 AMIMNN+4.40%
